Rapporto annuale 2007 - Istituto di Ricerche Farmacologiche Mario ...

IRFMN
SELEZIONE PUBBLICAZIONI SCIENTIFICHE APPARSE
NELL'ANNO 2007
Noris M, Casiraghi F, Todeschini M, Cravedi P, Cugini D, Monteferrante G, Aiello S, Cassis L, Gotti E, Gaspari F,
Cattaneo D, Perico N, Remuzzi G. “Lymphopenia and calcineurin signalling expand T regulatory cells in human
recipients of organ transplantation”. JASN 2007, 18:1007-1018.
Cattaneo D. Does IgA nephropathy affect long-term graft outcome after kidney transplantation? J PostGrad Med,
2007, 53:84.
Corna D, Sangalli F, Cattaneo D, Carrara F, Gaspari F, Remuzzi A, Zoja C, Benigni A, Perico N, Remuzzi G.
“Effects of rosuvastatin on glomerular capillary size-selectivity function in rats with renal mass ablation”. Am J
Nephrol 2007, 27:630-638.
Baldelli S, Merlini S, Cattaneo D, Nicastri A, Bartolini B, Perico N, Remuzzi G. “C-440T/T-331C polymorphisms in
the UGT-1A9 gene affect the pharmacokinetics of mycophenolic acid in renal transplant recipients”.
Pharmacogenomics, 2007, 8:1127-1141.
Carlucci F, Anzini M, Rovini M, Cattaneo D, S. Merlini S, Tabucchi A .”Development of a capillary electrophoresis
method for the determination of mycophenolic acid in human plasma: a comparison with HPLC”. Electrophoresis
2007, 28:3908-3914.
Cattaneo D, Cortinovis M, Baldelli S, Bitto A, Gotti E, Remuzzi G, Perico N. Pharmacokinetics of mycophenolate
sodium and comparison with the mofetil formulation in stable kidney transplant recipients. CJASN 2007, 2: 1147-
1155.
Ripamonti D, Cattaneo D, Airoldi M, Frigerio L, Bertuletti P, Ruggeri M, Suter F, Maggiolo F. Atazanavir plus lowdose
ritonavir in pregnancy: pharmacokinetics and placental transfer. AIDS 2007; 21:2409-2415.
Cravedi P, Ruggenenti P, Remuzzi G. Intensified inhibition of renin-angiotensin system: a way to improve renal
protection? Curr Hypertens Rep. 2007;9(5):430-6.
Ruggenenti P, Cravedi P, Remuzzi G. Latest treatment strategies for membranous nephropathy. Expert Opin
Pharmacother. 2007;8(18):3159-71.
Ruggenenti P, Perico N, Gotti E, Cravedi P, D'Agati V, Gagliardini E, Abbate M, Gaspari F, Cattaneo D, Noris M,
Casiraghi F, Todeschini M, Cugini D, Conti S, Remuzzi G. Sirolimus versus cyclosporine therapy increases
circulating regulatory T cells, but does not protect renal transplant patients given alemtuzumab induction from
chronic allograft injury. Transplantation. 2007;84(8):956-64.
Cravedi P, Noris M, Remuzzi G. Report of the first World Transplant Congress. Clin J Am Soc Nephrol.
2007;2(2):393-400.
Cravedi P, Ruggenenti P, Sghirlanzoni MC, Remuzzi G. Titrating rituximab to circulating B cells to optimize
lymphocytolytic therapy in idiopathic membranous nephropathy. Clin J Am Soc Nephrol. 2007;2(5):932-7.
Remuzzi G, Cravedi P, Costantini M, Lesti M, Ganeva M, Gherardi G, Ene-Iordache B, Gotti E, Donati D, Salvadori
M, Sandrini S, Segoloni G, Federico S, Rigotti P, Sparacino V, Ruggenenti P. Mycophenolate mofetil versus
azathioprine for prevention of chronic allograft dysfunction in renal transplantation: the MYSS follow-up
randomized, controlled clinical trial. J Am Soc Nephrol. 2007;18(6):1973-85.
Cravedi P, Ruggenenti P, Remuzzi G. Does remission of renal disease associated with antihypertensive treatment
exist? Curr Hypertens Rep. 2007;9(2):160-5.
Sanna-Cherchi S, Carnevali ML, Martorana D, Cravedi P, Maggiore U, Alinovi R, Bovino A, Mattei S, Orlandini G,
Gatti R, Savi M, Sado Y, Neri TM, Allegri L. Alterations of type IV collagen alpha chains in patients with chronic
acquired glomerulopathies: mRNA levels, protein expression and urinary loss. Am J Nephrol. 2007;27(2):129-37.
300
RAPPORTO ATTIVITA’ 2007